R.PR
REGISTERED-PRINCIPAL REGISTER
03/04/2025
Back to search
Official data from USPTO
CLINIDERM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
03/04/2025
Classification
Registered
Trademark type
Word
Nice classes
3, 5
Filing date
10/18/2022
Registration date
03/04/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2025
Last transaction
03/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Mississauga, Ontario, CA
Examiner
STINSON, JENNIFER ELLE
Law office
O20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Accelera Pharma Canada Inc.
Representatives
David M. Mello ONELLO & MELLO, LLP
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetic topical creams and lotions for non-medical use
Class 5
Medicated topical creams and lotions for treating skin conditions
Publications
History of USPTO decisions and trademark events.
27 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2025
PUBO
PUBLISHED FOR OPPOSITION
01/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/16/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/27/2024
GNSL
LETTER OF SUSPENSION E-MAILED
01/27/2024
CNSL
SUSPENSION LETTER WRITTEN
01/27/2024
DOCK
ASSIGNED TO EXAMINER
12/06/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/02/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/02/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2023
GNRT
NON-FINAL ACTION E-MAILED
08/03/2023
CNRT
NON-FINAL ACTION WRITTEN
08/03/2023
DOCK
ASSIGNED TO EXAMINER
08/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/08/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/08/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/08/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/12/2022
ALIE
ASSIGNED TO LIE
12/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/01/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/21/2022
NWAP
NEW APPLICATION ENTERED
10/21/2022
Continuous trademark protection
Get notified about every new filing that threatens CLINIDERM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.